These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38750336)

  • 1. Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.
    Attar ES; Jayakumar S; Devarajan PV
    AAPS PharmSciTech; 2024 May; 25(5):113. PubMed ID: 38750336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.
    Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y
    Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
    Feng R; Song Z; Zhai G
    Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM; Devarajan PV
    Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.
    Shrotriya S; Ranpise N; Satpute P; Vidhate B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin.
    Caon T; Mazzarino L; Simões CM; Senna EL; Silva MA
    AAPS PharmSciTech; 2017 Apr; 18(3):920-925. PubMed ID: 27230504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the bioavailability of curcumin by a supersaturatable self nanoemulsifying drug delivery system with incorporation of a hydrophilic polymer: in vitro and in vivo characterisation.
    Chen XL; Liang XL; Zhao GW; Zeng QY; Dong W; Ou LQ; Zhang HN; Jiang QY; Liao ZG
    J Pharm Pharmacol; 2021 Mar; 73(5):641-652. PubMed ID: 33772289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
    Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
    Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
    Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
    Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
    Sharma JB; Bhatt S; Saini V; Kumar M
    Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment.
    Hazzah HA; Farid RM; Nasra MMA; Hazzah WA; El-Massik MA; Abdallah OY
    J Pharm Sci; 2015 Nov; 104(11):3913-3924. PubMed ID: 26202796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake.
    Bachhav SS; Dighe VD; Kotak D; Devarajan PV
    Int J Pharm; 2017 Oct; 532(1):612-622. PubMed ID: 28935258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pectin-decorated selenium nanoparticles as a nanocarrier of curcumin to achieve enhanced physicochemical and biological properties.
    Wu Y; Liu H; Li Z; Huang D; Nong L; Ning Z; Hu Z; Xu C; Yan JK
    IET Nanobiotechnol; 2019 Oct; 13(8):880-886. PubMed ID: 31625531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery.
    Le-Vinh B; Steinbring C; Wibel R; Friedl JD; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2021 Jun; 163():109-119. PubMed ID: 33775852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.